Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:55 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 642 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pilot Randomized Controlled Trial Clear all

Conditions: Thoracic Aortic Aneurysm
Interventions: Spironolactone, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breastfeeding, Exclusive, Breastfeeding
Interventions: Donor Breast Milk; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 3 Days
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Osteoarthritis
Interventions: Sensor-assisted TKR (Verasense), Control - Without the use of Verasense; Device · Procedure
Lead sponsor: Orthosensor, Inc.; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Influenza
Interventions: HD Fluzone Vaccine, SD Fluzone Vaccine; Biological
Lead sponsor: Insight Therapeutics, LLC; Other
Eligibility: 65 Years and older
Enrollment: 2,957 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Providence, Rhode Island • Norfolk, Virginia

Conditions: Development, Human, Well-Being, Professional Burnout, Goals, Leadership, Professional Role, Physician's Role, Stress, Anxiety
Interventions: Professional coaching; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Migraine, Classic
Interventions: Chiropractic Treatment; Other
Lead sponsor: Harvard University Faculty of Medicine; Other
Eligibility: 20 Years to 55 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hyperplasia, Chronic Renal Failure
Interventions: edifoligide (E2F Decoy); Drug
Lead sponsor: Anesiva, Inc.; Industry
Eligibility: 18 Years to 79 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 21
States / cities: Los Angeles, California • Hudson, Florida • Miami, Florida + 15 more

Conditions: Pregnancy Related
Interventions: Water Birth; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Chronic Kidney Diseases
Interventions: Active taVNS, Sham taVNS; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2D6-RELATED, Drug Metabolism, Poor, CYP2C19-RELATED, Cytochrome P450 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Interventions: Pharmacogenetic testing; Genetic
Lead sponsor: Genelex Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Searcy, Arkansas

Conditions: Spontaneous Abortion in First Trimester
Interventions: Vaginal Misoprostol, Buccal Misoprostol; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: La Jolla, California • San Diego, California

Conditions: Migraine Headache
Interventions: Normal saline (1000 mL), Control; Other
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Sjogren's Syndrome, Keratoconjunctivitis Sicca
Interventions: Levocarnitine, Placebo; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Dietary Habits, Physical Inactivity, Sleep Hygiene
Interventions: Experimental; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neurocognitive Disorders, Cognitive Dysfunction, Traumatic Brain Injury, Multiple Sclerosis, Mild Cognitive Impairment
Interventions: CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Subsyndromal Delirium
Interventions: Haloperidol decanoate, Placebo; Drug
Lead sponsor: Northeastern University; Other
Eligibility: 18 Years to 84 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Depression, Anxiety, Stress, Stroke
Interventions: acceptance and commitment therapy (ACT); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Physical Inactivity
Interventions: Mindful Movement, 10 Keys to Health & Wellbeing; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Edina, Minnesota • Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Menopausal Osteoporosis
Interventions: VSL#3, Placebo; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM), CKD Stage 3, CKD Stage 4, CKD Stage 5, Diabetes Mellitus, Diabetic Kidney Disease
Interventions: PLAFOND diet; Dietary Supplement
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Orange, California • Torrance, California

Conditions: Burn, Scar, Exercise Therapy
Interventions: paraffin wax, standard of care exercise therapy; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Autism Spectrum Disorder, Autism
Interventions: Pregnenolone, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 14 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Ivacaftor, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Interventions: topical ruxolitinib 1.5% cream, Topical vehicle/moisturizer cream; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 12 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

HEART: Pilot Randomized Controlled Trial

Donor Breast Milk and Breastfeeding Rates

Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing

High Dose Influenza Vaccine in Nursing Home - Pilot Study

The Impact of Professional Coaching on Early Career Academic Emergency Physicians

Integrative Migraine Pain Alleviation Through Chiropractic Therapy

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

Pharmacogenetic Testing Among Home Health Patients

Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss

Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

Levocarnitine for Dry Eye in Sjogren's Syndrome

HEART at Head Start Pilot (Healthy Eating, Activity, Relaxation Trial)

A Pilot Randomized Controlled Trial: CoINTEGRATE

Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol

A Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention for Stroke Survivors

Mindful Movement for Physical Activity and Wellbeing in Older Adults

Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women

Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease

Paraffin Wax and Exercise Prospective

Pilot Trial of Pregnenolone in Autism

TOPIC Trial for COPD

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease